Connable Office’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Connable Office's TEVA Position: Q3 2026 in Review
Connable Office reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 4.1% in Q3 2026, selling an estimated $45.8K and leaving 29,832 shares worth $1.18M. The position accounts for 0.1% of the portfolio, ranked #88.
Connable Office first reported a position in TEVA in Q1 2014 and has held it in 15 quarters since. The position peaked at $1.36M in Q3 2016. 477 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.
- Connable Office held 29,832 shares of Teva Pharmaceutical Industries Limited worth $1.18M as of Q3 2026.
- Connable Office sold 1,282 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $45.8K.
- Teva Pharmaceutical Industries Limited made up 0.1% of Connable Office's portfolio in Q3 2026, its #88 holding.
- Connable Office first reported a position in Teva Pharmaceutical Industries Limited in Q1 2014 and has held it in 15 quarters since.
- Connable Office's Teva Pharmaceutical Industries Limited position peaked at $1.36M in Q3 2016.
- 477 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.
Based on Connable Office's 13F filing for Q3 2026, filed 10 Nov 2026.